Top Markets
#1 Official Trump Official Trump +44.68%
#2 Melania Meme Melania Meme +22.66%
#3 EXOD EXOD +18.93%
#4 Movement Movement +18.56%
#5 Wrapped STX (Velar) Wrapped STX (Velar) +17.59%
#6 Wrapped POL Wrapped POL +16.68%
#7 POL (ex-MATIC) POL (ex-MATIC) +16.52%
#8 Mubarak Mubarak +15.50%
#9 Unit Pump Unit Pump +11.33%
#10 Pump.fun Pump.fun +10.98%
Coin of the day
Official Trump Official Trump
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classement en actions #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Prix de l'action
$0.17616661
Dernière synchronisation: 2026-08-21
Capitalisation boursière
$73.48M
Changement (1 jour)
0.18%
Changement (1 an)
-37.76%
Pays
TW
Échange Mercury Biopharmaceutical Corporation (6932)

Catégorie

Healthcare
Ratio P/S pour Mercury Biopharmaceutical Corporation (6932)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Mercury Biopharmaceutical Corporation, le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Mercury Biopharmaceutical Corporation de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
- -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
- -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
- -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
- -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
7.73 -
IN